We are live on ! Find out more
BEAT

BioTelemetry, Inc.
BEAT

Delisted

BEAT was delisted on the 8th of February, 2021.

167 hedge funds and large institutions have $430M invested in BioTelemetry, Inc. in 2016 Q3 according to their latest regulatory filings, with 43 funds opening new positions, 55 increasing their positions, 58 reducing their positions, and 15 closing their positions.

New
Increased
Maintained
Reduced
Closed

187% more first-time investments, than exits

New positions opened: 43 | Existing positions closed: 15

20% more capital invested

Capital invested by funds: $358M → $430M (+$72.2M)

20% more funds holding

Funds holding: 139167 (+28)

5% less repeat investments, than reductions

Existing positions increased: 55 | Existing positions reduced: 58

15% less call options, than puts

Call options by funds: $3.88M | Put options by funds: $4.58M

50% less funds holding in top 10

Funds holding in top 10: 42 (-2)

Holders
167
Holders Change
+28
Holders Change %
+20.14%
% of All Funds
4.46%
Holding in Top 10
2
Holding in Top 10 Change
-2
Holding in Top 10 Change %
-50%
% of All Funds
0.05%
New
43
Increased
55
Reduced
58
Closed
15
Calls
$3.88M
Puts
$4.58M
Net Calls
-$697K
Net Calls Change
+$1.01M
Name Holding Trade Value Shares
Change
Change in
Stake
Two Sigma Investments
26
Two Sigma Investments
New York
$4.42M +$1.46M +77,434 +48%
ACM
27
Argent Capital Management
Missouri
$4.18M -$447K -23,720 -10%
AQR Capital Management
28
AQR Capital Management
Connecticut
$4.17M +$1.42M +75,552 +51%
Principal Financial Group
29
Principal Financial Group
Iowa
$3.81M +$3.87M +205,215 New
Geode Capital Management
30
Geode Capital Management
Massachusetts
$3.8M +$243K +12,883 +7%
Ameriprise
31
Ameriprise
Minnesota
$3.78M +$2.33M +123,681 +154%
OAM
32
Oxford Asset Management
United Kingdom
$3.75M +$1.67M +88,694 +78%
EI
33
EAM Investors
California
$3.74M -$207K -10,968 -5%
SFM
34
Systematic Financial Management
New Jersey
$3.32M -$467K -24,740 -12%
New York State Common Retirement Fund
35
New York State Common Retirement Fund
New York
$3.31M -$612K -32,460 -15%
D.E. Shaw & Co
36
D.E. Shaw & Co
New York
$3.17M -$4.6M -243,693 -59%
California Public Employees Retirement System
37
California Public Employees Retirement System
California
$2.97M
GCP
38
GSA Capital Partners
United Kingdom
$2.87M -$218K -11,540 -7%
IA
39
Icon Advisers
Colorado
$2.67M -$1.64M -86,754 -38%
TA
40
Teton Advisors
New York
$2.66M -$37.7K -2,000 -1%
ICRM
41
Insight Capital Research & Management
California
$2.57M +$2.61M +138,203 New
AA
42
Ancora Advisors
Ohio
$2.45M +$714K +37,836 +40%
BCM
43
Bridgeway Capital Management
Texas
$2.37M -$852K -45,200 -26%
GC
44
Globeflex Capital
California
$2.36M -$1.89K -100 -0.1%
Two Sigma Advisers
45
Two Sigma Advisers
New York
$2.24M +$2.06M +109,300 +950%
BIM
46
BlackRock Investment Management
Delaware
$2.16M +$227K +12,037 +12%
Invesco
47
Invesco
Georgia
$2.16M +$1.23M +64,961 +127%
AIC
48
AWM Investment Company
New York
$2.03M -$675K -35,811 -25%
GC
49
Guggenheim Capital
Illinois
$2.01M +$2.04M +108,225 New
SCA
50
Secor Capital Advisors
New York
$2M +$441K +23,359 +28%

BEAT Hedge Fund Activity: Q3 2016 in Review

167 of the 3,748 institutional investors tracked by Wall St. Rank reported a position in BioTelemetry, Inc. (BEAT) for Q3 2016, worth a combined $430M — up 20% from $358M a quarter earlier.

Buyers outnumbered sellers: 43 funds opened new BEAT positions and 15 closed out — a net gain of 28 holders — while 55 added to existing stakes and 58 trimmed.

The largest buyer was BlackRock Fund Advisors, adding an estimated $23.3M. The largest seller was Cannell Capital, cutting an estimated $7.91M.

  • 167 institutional investors held BioTelemetry, Inc. (BEAT) as of Q3 2016, up from 139 in Q2 2016.
  • Funds reported $430M of BioTelemetry, Inc. stock for Q3 2016, up 20% quarter-over-quarter.
  • 43 funds opened new BioTelemetry, Inc. positions in Q3 2016 and 15 closed out, a net change of +28 holders.
  • The largest BioTelemetry, Inc. buyer in Q3 2016 was BlackRock Fund Advisors, an estimated $23.3M added.
  • The largest BioTelemetry, Inc. seller in Q3 2016 was Cannell Capital, an estimated $7.91M sold.

Based on aggregated 13F filings for Q3 2016.